http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
K. M. Geetha,Jyotsna Shankar,Barnabas Wilson 경희대학교 융합한의과학연구소 2023 Oriental Pharmacy and Experimental Medicine Vol.23 No.4
Chia seed oil (CSO) was reported to possess various pharmacological effects, however, its usefulness is restricted due to its inadequate solubility, bioavailability and stability. In the present work, efforts were put forward to develop chia seed oil nanoemulsion (CSO NE). The developed CSO NE was exposed to pharmacodynamic evaluation against Parkinson’s disease (PD) induced by rotenone (RT) in the mice. Here, the animals were classified into 6 groups: (I) Vehicle control, (II) RT (1 mg/ kg s.c.), (III) CSO (200 mg/kg p.o.) + RT, (IV) CSO (400 mg/kg p.o.) + RT, (V) CSO NE (200 mg/kg p.o.) + RT, (VI) CSO NE (400 mg/kg p.o.) + RT. Animals received the treatment 30 min before RT administration for 14 days. The outcomes of the motor/behavioural evaluations (rotarod test and locomotor activity), biochemical evaluations (estimation of malondialdehyde, nitrite, acetylcholine esterase, reduced glutathione, catalase and superoxide dismutase) and histopathological evaluation affirmed that the CSO NE treatment rendered a significant enhancement in the neuroprotective effects as compared to CSO administered alone. These results suggest that the oral bioavailability of CSO was escalated by its conversion to nanoform, thus imparting greater neuroprotection. The potential application of CSO NE was established in the management of PD.